Back | Next |
home / stock / hils / hils message board
Subject | By | Source | When |
---|---|---|---|
short squeeze all day | gail | investorshub | 04/18/2023 11:15:45 AM |
$HILS Price gaining up | gail | investorshub | 04/18/2023 7:54:20 AM |
what does this mean? | harry crumb | investorshub | 04/18/2023 1:22:22 AM |
$HILS news out | harry crumb | investorshub | 04/17/2023 10:16:14 PM |
Price now up | Runners123 | investorshub | 04/17/2023 9:54:37 PM |
still watching. | gail | investorshub | 04/17/2023 6:19:15 PM |
$HILS great news | velcro | investorshub | 04/17/2023 8:53:50 AM |
$HILS good read | Triple nickle | investorshub | 04/17/2023 2:41:20 AM |
$HILS Price now | subslover | investorshub | 04/16/2023 10:12:35 PM |
The trading | Spuds McKenz66 | investorshub | 04/16/2023 8:11:01 PM |
Good read | gail | investorshub | 04/16/2023 11:42:45 AM |
$HILS Price now | harry crumb | investorshub | 04/16/2023 8:59:09 AM |
Price now up | harry crumb | investorshub | 04/16/2023 6:53:17 AM |
what does this mean? | subslover | investorshub | 04/16/2023 1:00:48 AM |
should we be shorting? | harry crumb | investorshub | 04/15/2023 9:31:57 PM |
$HILS Time for this to show some returns | subslover | investorshub | 04/15/2023 8:51:46 PM |
$HILS Price trading up | harry crumb | investorshub | 04/15/2023 1:54:27 PM |
short squeeze article | bud_fox | investorshub | 04/15/2023 10:15:25 AM |
$HILS Thoughts on where this is headed? | subslover | investorshub | 04/15/2023 9:59:05 AM |
$HILS should we be shorting? | tw0122 | investorshub | 04/15/2023 6:46:52 AM |
News, Short Squeeze, Breakout and More Instantly...
Hillstream BioPharma Inc. Company Name:
HILS Stock Symbol:
NASDAQ Market:
Expects to launch and complete a Phase 1 trial in Q4 2023 Tharimmune to begin trading under new ticker, THAR, on Monday September 25, 2023 BRIDGEWATER, NJ / ACCESSWIRE / September 22, 2023 / Hillstream BioPharma Inc., (NASDAQ:HILS), a biotechnology company developing innovative therapeu...
JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8 th Annual Dawson James Small Cap Growth Conferen...
Anticipate completion of Phase 1 & Phase 2 clinical trials in chronic pruritis over the next approximately 12 months Seeking first approval in an orphan disease, PBC, for the treatment of moderate to severe chronic pruritis in which more than 70% of patients suffer from chronic prur...